SOPHiA GENETICS SA (SOPH) Reports Q2 Loss, Lags Revenue Estimates – August 9, 2022

SOPHiA GENETICS SA (SOPH Quick QuoteSOPH – Free Report) came out with a quarterly loss of $0.39 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.31 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would … Read more

Myriad Genetics (MYGN) Q2 Earnings Top, Gross Margin Down – August 5, 2022

Myriad Genetics, Inc. (MYGN Quick QuoteMYGN – Free Report) reported adjusted earnings per share (EPS) of 4 cents in the second quarter of 2022, surpassing the Zacks Consensus Estimate of an adjusted EPS of 2 cents. However, the metric plunged 66.7% from the year-ago quarter’s figure of 12 cents. The quarter’s adjustments exclude certain acquisition-amortization … Read more

Fulgent Genetics, Inc. (FLGT) Q2 Earnings and Revenues Beat Estimates – August 4, 2022

Fulgent Genetics, Inc. (FLGT Quick QuoteFLGT – Free Report) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $2.55 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 6.85%. A … Read more

Seattle Genetics (SGEN) Reports Q2 Loss, Tops Revenue Estimates – July 28, 2022

Seattle Genetics (SGEN Quick QuoteSGEN – Free Report) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of $0.82. This compares to a loss of $0.47 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of … Read more